| Sandra Lee Parker, | |
|
1425 N Randall Rd, Elgin, IL 60123-2300 | |
| (224) 783-1570 | |
| Not Available |
| Full Name | Sandra Lee Parker |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1425 N Randall Rd, Elgin, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073219903 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 0413933343 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sandra Lee Parker, 7216 W Coyle Ave, Chicago, IL 60631-1109 Ph: (847) 293-3710 | Sandra Lee Parker, 1425 N Randall Rd, Elgin, IL 60123-2300 Ph: (224) 783-1570 |
News Archive
Phase II trial findings have ruled out a combination of erlotinib and everolimus for advanced non-small-cell lung cancer patients with progression after chemotherapy.
Trust for America's Health commends today's announcement by the U.S. Department of Health and Human Services of Communities Putting Prevention to Work grantee recipients. The landmark $327 million initiative will provide funding for a comprehensive, coordinated approach to community-based prevention activities that address physical activity, nutrition, obesity, and tobacco use.
The UK's National Physical Laboratory with the University of Edinburgh and IBM's TJ Watson Research Center have published new research about the structure of an HIV-1 protein that could help to develop new drugs to stop the virus infecting healthy cells.
Almost a year in the making, a federal plan to prioritize research on the potential environmental, health, and safety (EHS) impacts of nanoscale materials has so many failings that its begs the question as to whether the government's 13-agency nanotechnology research effort is able to deliver an effective risk research strategy, according to David Rejeski, head of the Wilson Center's Project on Emerging Nanotechnologies.
The U.S. Food and Drug Administration (FDA) today announced approval of Follistim®-AQ TM cartridge (follitropin beta injection) in the United States. Follistim-AQ cartridge is the first follicle stimulating hormone (FSH) treatment available in a pre-filled, pre-mixed solution, eliminating the need for patients to mix one or more vials of medication.
› Verified 4 days ago
Danielle Bryant, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 745 Fletcher Dr Ste 101, Elgin, IL 60123 Phone: 847-742-3525 Fax: 847-742-3585 | |
Shay Lynn Ward, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1752 Capital St, Elgin, IL 60124 Phone: 847-695-3680 Fax: 847-695-4552 | |
Tiffany Robinson, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 50 S Grove Ave Unit 308, Elgin, IL 60120 Phone: 312-581-8000 | |
Jaclyn Mastrangeli, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1425 N Randall Rd, Elgin, IL 60123 Phone: 847-742-9800 | |
Ms. Suzanne Marie Butler, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 77 N Airlite St, Elgin, IL 60123 Phone: 847-888-3946 | |
Rosario I Sanchez Prinicipe, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 87 N Airlite St, Elgin, IL 60123 Phone: 847-888-3661 |